Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
0.5063
+0.0214 (4.41%)
At close: Sep 23, 2026, 4:00 PM EDT
0.5100
+0.0037 (0.73%)
After-hours: Sep 23, 2026, 7:42 PM EDT
Bone Biologics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Selling, General & Admin | 2.17 | 2.22 | 2.17 | 2.15 | 2.14 | 2.05 | 2.09 | 2.35 | 2.34 | 2.62 | 2.52 | 2.34 | 2.28 | 1.99 | 2.09 | 1.98 | 1.76 | 1.54 | 1.02 | 0.78 |
Research & Development | 0.9 | 0.78 | 1.06 | 1.91 | 2.15 | 2.31 | 2.13 | 1.47 | 2.62 | 4.56 | 6.91 | 7.22 | 6.41 | 4.13 | 1.58 | 0.86 | 0.09 | 0.07 | 0.08 | 0.07 |
Operating Expenses | 3.06 | 3 | 3.23 | 4.06 | 4.29 | 4.35 | 4.22 | 3.82 | 4.95 | 7.18 | 9.43 | 9.56 | 8.69 | 6.12 | 3.67 | 2.84 | 1.85 | 1.61 | 1.1 | 0.85 |
Operating Income | -3.06 | -3 | -3.23 | -4.06 | -4.29 | -4.35 | -4.22 | -3.82 | -4.95 | -7.18 | -9.43 | -9.56 | -8.69 | -6.12 | -3.67 | -2.84 | -1.85 | -1.61 | -1.1 | -0.85 |
Interest Expense | - | - | - | - | - | - | - | - | - | - | - | -0.73 | -0.73 | -0.73 | -0.73 | -0.01 | -0.29 | -0.55 | -0.81 | -1.04 |
Interest & Investment Income | 0.17 | 0.14 | 0.12 | 0.09 | 0.07 | 0.08 | 0.06 | 0.04 | 0.02 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - |
Other Non Operating Income (Expenses) | 0 | 0 | 0 | 0.02 | 0.01 | 0.02 | 0.05 | 0.06 | 0.23 | 1.49 | 0.89 | 3.78 | 3.62 | 2.35 | 2.91 | - | - | - | - | - |
EBT Excluding Unusual Items | -2.89 | -2.86 | -3.11 | -3.95 | -4.22 | -4.26 | -4.11 | -3.73 | -4.7 | -5.69 | -8.53 | -6.51 | -5.8 | -4.51 | -1.48 | -2.85 | -2.14 | -2.17 | -1.91 | -1.89 |
Legal Settlements | - | - | - | - | - | - | - | -0.41 | -0.41 | -0.41 | -0.41 | - | - | - | - | - | - | - | - | - |
Other Unusual Items | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.3 | 0.3 | 0.3 | 0.3 | - |
Pretax Income | -2.89 | -2.86 | -3.11 | -3.95 | -4.22 | -4.26 | -4.11 | -4.14 | -5.12 | -6.1 | -8.95 | -6.51 | -5.8 | -4.51 | -1.48 | -2.56 | -1.85 | -1.87 | -1.61 | -1.89 |
Net Income | -2.89 | -2.86 | -3.11 | -3.95 | -4.22 | -4.26 | -4.11 | -4.14 | -5.12 | -6.1 | -8.95 | -6.51 | -5.8 | -4.51 | -1.48 | -2.56 | -1.85 | -1.87 | -1.61 | -1.89 |
Preferred Dividends & Other Adjustments | - | - | - | - | 3.21 | 3.21 | 3.21 | 3.21 | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income to Common | -2.89 | -2.86 | -3.11 | -3.95 | -7.43 | -7.48 | -7.32 | -7.35 | -5.12 | -6.1 | -8.95 | -6.51 | -5.8 | -4.51 | -1.48 | -2.56 | -1.85 | -1.87 | -1.61 | -1.89 |
Net Income Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding (Basic) | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - |
Shares Outstanding (Diluted) | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | - | - |
Shares Change (YoY) | 301.20% | 316.40% | 364.45% | 390.51% | 369.80% | 422.02% | 476.80% | 518.56% | 230.18% | - | - | - | - | - | - | - | - | - | - | - |
EPS (Basic) | -1.61 | -1.92 | -2.65 | -4.77 | -16.56 | -20.88 | -28.96 | -43.58 | -53.58 | -89.00 | -204.05 | -238.49 | -200.62 | - | - | - | - | - | - | - |
EPS (Diluted) | -1.61 | -1.92 | -2.65 | -4.77 | -16.56 | -20.88 | -28.96 | -43.58 | -53.58 | -89.00 | -204.05 | -238.49 | -200.62 | - | - | - | - | - | - | - |
EPS Growth (YoY) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Additional Metrics
Fiscal Quarter | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Free Cash Flow | -2.63 | -2.57 | -2.69 | -3.33 | -3.31 | -3.75 | -4.12 | -4.79 | -6.77 | -9.51 | -9.56 | -9.49 | -7.33 | -4.06 | -3.57 | -1.8 | -1.69 | -1.96 | -1.23 | -1.17 |
Free Cash Flow Per Share | -1.46 | -1.72 | -2.29 | -4.02 | -7.38 | -10.47 | -16.31 | -28.39 | -70.89 | -138.63 | -217.89 | -347.86 | -253.28 | - | - | - | - | - | - | - |
EBIT | -3.06 | -3 | -3.23 | -4.06 | -4.29 | -4.35 | -4.22 | -3.82 | -4.95 | -7.18 | -9.43 | -9.56 | -8.69 | -6.12 | -3.67 | -2.84 | -1.85 | -1.61 | -1.1 | -0.85 |